EV/EBITDA
-2.83
+0.19+6.29%
Sat, 22 Feb 2025 00:00:59 GMT
Summary
- As of February 24, 2025, KALV EV/EBITDA is -2.83, with a rise of +0.19 (+6.29%) during the most recent trading day.
- Over the past year, KALV EV/EBITDA has increased by +1.53 (+35.09%).
- KALV EV/EBITDA is now -289.93% below its all-time high of 1.49.
Performance
KALV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KALV EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +6.3% | -6.5% | -6.0% |
1 m1 month | -13.2% | +12.9% | +11.9% |
3 m3 months | -2.5% | +2.5% | +1.9% |
6 m6 months | +19.8% | -11.2% | -20.5% |
ytdytd | -16.5% | +16.3% | +14.9% |
1 y1 year | +35.1% | -14.4% | -24.6% |
5 y5 years | +48.4% | +97.7% | -28.4% |
KALV EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -17.9% | -3.06 | +7.5% | |
3 m | 3-month | -2.04 | -38.7% | -3.06 | +7.5% |
6 m | 6-month | -2.04 | -38.7% | -3.67 | +22.9% |
1 y | 1-year | -2.04 | -38.7% | -4.95 | +42.8% |
3 y | 3-year | -0.72 | -293.1% | -4.95 | +42.8% |
5 y | 5-year | -0.72 | -293.1% | -20.76 | +86.4% |
alltime | all time | 1.49 | -289.9% | -22.62 | +87.5% |
KalVista Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -2.83(+16.5%) |
2024 | -2.43(-32.5%) |
2023 | -3.60(+88.5%) |
2022 | -1.91(-50.8%) |
2021 | -3.88(-42.4%) |
Date | Value |
---|---|
2020 | -6.74(-17.8%) |
2019 | -8.20(-29.1%) |
2018 | -11.56(+265.8%) |
2017 | -3.16(+92.7%) |
2016 | -1.64(-16.3%) |
2015 | -1.96 |
FAQ
- What is KalVista Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for KalVista Pharmaceuticals?
- What is KALV EV/EBITDA year-to-date change?
- What is KalVista Pharmaceuticals EV/EBITDA year-on-year change?
What is KalVista Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of KALV is -2.83
What is the all time high EV/EBITDA for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high EV/EBITDA is 1.49
What is KALV EV/EBITDA year-to-date change?
KalVista Pharmaceuticals EV/EBITDA has changed by -0.40 (-16.46%) since the beginning of the year
What is KalVista Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, KALV EV/EBITDA has changed by +1.53 (+35.09%)